Organogenesis Holdings (ORGO) Non-Current Deffered Revenue: 2016-2020
Historic Non-Current Deffered Revenue for Organogenesis Holdings (ORGO) over the last 4 years, with Sep 2020 value amounting to $1.1 million.
- Organogenesis Holdings' Non-Current Deffered Revenue rose 49.18% to $1.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.1 million, marking a year-over-year increase of 49.18%. This contributed to the annual value of $1.0 million for FY2019, which is 678.46% up from last year.
- Latest data reveals that Organogenesis Holdings reported Non-Current Deffered Revenue of $1.1 million as of Q3 2020, which was up 0.09% from $1.1 million recorded in Q2 2020.
- Over the past 5 years, Organogenesis Holdings' Non-Current Deffered Revenue peaked at $10.8 million during Q4 2016, and registered a low of $74,000 during Q4 2017.
- Its 3-year average for Non-Current Deffered Revenue is $3.0 million, with a median of $1.1 million in 2020.
- Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first crashed by 99.32% in 2017, then soared by 678.46% in 2019.
- Organogenesis Holdings' Non-Current Deffered Revenue (Quarterly) stood at $10.8 million in 2016, then tumbled by 99.32% to $74,000 in 2017, then spiked by 75.68% to $130,000 in 2018, then surged by 678.46% to $1.0 million in 2019, then spiked by 49.18% to $1.1 million in 2020.
- Its Non-Current Deffered Revenue was $1.1 million in Q3 2020, compared to $1.1 million in Q2 2020 and $1.1 million in Q1 2020.